Hongqi Chen

600 Yishan Road
Shanghai, 200233, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications

Metapath2vec and attention-driven heterogeneous graph learning for prioritizing TCM-derived small molecules in gastric cancer.

Metapath2vec and attention-driven heterogeneous graph learning for prioritizing TCM-derived small molecules in gastric cancer.

Journal: Chinese medicine
Published: March 11, 2026

A multi-omics dissection of INHBA+ CAF-mediated epithelial-mesenchymal transition and immune suppression in colorectal cancer.

A multi-omics dissection of INHBA+ CAF-mediated epithelial-mesenchymal transition and immune suppression in colorectal cancer.

Journal: Journal of translational medicine
Published: January 30, 2026

Cannabidiol suppresses emergency MDSCs generation by disturbing EEF1B2-mediated C/EBPβ protein synthesis in colorectal adenomas.

Cannabidiol suppresses emergency MDSCs generation by disturbing EEF1B2-mediated C/EBPβ protein synthesis in colorectal adenomas.

Journal: Journal for immunotherapy of cancer
Published: December 23, 2025

Integrating machine learning and multi-omics analysis to explore Treg-associated programmed cell death features in clear cell renal cell carcinoma.

Integrating machine learning and multi-omics analysis to explore Treg-associated programmed cell death features in clear cell renal cell carcinoma.

Journal: Cancer cell international
Published: October 16, 2025

Specific inhibitor to KRASG12C induces tumor-specific immunity and synergizes with oncolytic virus for enhanced cancer immunotherapy.

Specific inhibitor to KRASG12C induces tumor-specific immunity and synergizes with oncolytic virus for enhanced cancer immunotherapy.

Journal: Journal for immunotherapy of cancer
Published: July 07, 2025

KLK1 as an Epithelial-Specific Brake Inhibits Colorectal Tumorigenesis by Suppressing B1R-Mediated Fibroblast Phenotypic Transition.

KLK1 as an Epithelial-Specific Brake Inhibits Colorectal Tumorigenesis by Suppressing B1R-Mediated Fibroblast Phenotypic Transition.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: April 24, 2025

BAX-mediated ammonia-driven cell death: a novel prognostic and therapeutic target in clear cell renal cell carcinoma.

BAX-mediated ammonia-driven cell death: a novel prognostic and therapeutic target in clear cell renal cell carcinoma.

Journal: Human genomics
Published: April 07, 2025

Targeting MAPK14 by Lobeline Upregulates Slurp1-Mediated Inhibition of Alternative Activation of TAM and Retards Colorectal Cancer Growth.

Targeting MAPK14 by Lobeline Upregulates Slurp1-Mediated Inhibition of Alternative Activation of TAM and Retards Colorectal Cancer Growth.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: July 11, 2024

Tumor immune dysfunction and exclusion subtypes in bladder cancer and pan-cancer: a novel molecular subtyping strategy and immunotherapeutic prediction model.

Tumor immune dysfunction and exclusion subtypes in bladder cancer and pan-cancer: a novel molecular subtyping strategy and immunotherapeutic prediction model.

Journal: Journal of translational medicine
Published: December 31, 2023

Diamond-Like Carbon Depositing on the Surface of Polylactide Membrane for Prevention of Adhesion Formation During Tendon Repair.

Diamond-Like Carbon Depositing on the Surface of Polylactide Membrane for Prevention of Adhesion Formation During Tendon Repair.

Journal: Nano-micro letters
Published: December 23, 2023

Identification of an immune-related eRNA prognostic signature for clear cell renal cell carcinoma.

Identification of an immune-related eRNA prognostic signature for clear cell renal cell carcinoma.

Journal: Aging
Published: August 15, 2023

Cuproptosis in ccRCC: key player in therapeutic and prognostic targets.

Cuproptosis in ccRCC: key player in therapeutic and prognostic targets.

Journal: Frontiers in oncology
Published: August 03, 2023
Showing 1-12 of 33

Last Updated: 09/26/2026